background
nonsever
acut
respiratori
syndrom
nonsar
relat
human
coronavirus
hcov
includ
detect
respiratori
tract
sampl
children
adult
howev
natur
preval
antibodi
virus
serum
among
popul
unknown
method
measur
antibodi
spike
protein
four
common
nonsar
hcov
recombin
protein
four
hcov
express
characteris
cell
sproteinbas
indirect
immunofluoresc
assay
ifa
develop
detect
anti
igg
igm
four
individu
hcov
appli
serum
sampl
gener
asymptomat
popul
children
adult
beij
result
blood
sampl
test
neg
anti
igg
seroposit
four
anti
igg
antibodi
within
gener
popul
major
seroconvers
fourhcov
posit
first
occur
children
sigg
sigm
antibodi
detect
among
children
increas
age
reach
plateau
year
age
howev
anti
igm
detect
healthi
adult
conclus
larg
proport
children
adult
beij
evid
anti
igg
four
hcov
first
infect
four
nonsar
hcov
take
place
childhood
coronavirus
positivesens
singlestrand
rna
virus
found
human
wide
varieti
anim
human
four
respiratori
coronavirus
name
human
coronaviru
hcov
endem
worldwid
four
common
strain
caus
diseas
mild
febril
upper
respiratori
tract
ill
sever
outcom
croup
bronchiol
pneumonia
attribut
upper
lower
respiratori
tract
infect
hospitalis
children
previous
unknown
coronaviru
caus
outbreak
sever
acut
respiratori
syndrom
sar
human
recent
novel
betacoronaviru
speci
hcovemc
identifi
man
pneumonia
saudi
arabia
coronavirus
phenotyp
genotyp
divers
coronavirus
possess
common
genom
organis
replicas
gene
encompass
twothird
genom
compris
two
overlap
open
read
frame
structur
gene
region
cover
third
genom
encod
canon
set
structur
protein
gene
order
envelop
e
membran
nucleocapsid
n
protein
immunodomin
cov
protein
common
method
diagnos
hcov
infect
revers
transcript
polymeras
chain
reaction
rtpcr
realtim
rtpcr
use
rna
extract
respiratori
tract
sampl
nasopharyng
aspir
hand
serolog
assay
detect
antibodi
hcov
complex
establish
howev
determin
level
immunoglobulin
igm
immunoglobulin
g
igg
antibodi
appropri
serum
plasma
sampl
allow
research
defin
point
time
primari
infect
well
exposur
rate
seroepidemiolog
studi
also
import
tool
hcov
infect
diagnosi
research
previou
report
indic
immunofluoresc
assay
ifa
detect
seroconvers
igg
antibodi
main
structur
n
protein
sarscov
use
diagnosi
acut
sarscov
infect
littl
current
known
preval
anti
antibodi
specif
nonsar
hcov
infect
among
children
adult
propos
ifa
detect
igg
structur
n
protein
nonsar
hcov
may
suitabl
seroepidemiolog
studi
expand
epidemiolog
knowledg
four
nonsarsrel
endem
hcov
china
express
protein
eukaryot
system
establish
ifa
detect
igg
igm
antibodi
four
virus
use
system
determin
preval
anti
igg
igm
antibodi
hcov
among
gener
popul
beij
serum
sampl
obtain
gener
asymptomat
popul
month
year
age
visit
hospit
medic
examin
vaccin
beij
aspect
studi
perform
accord
nation
ethic
regul
approv
institut
review
board
centr
diseas
control
prevent
china
ethic
committe
peke
union
medic
colleg
hospit
particip
receiv
written
inform
regard
purpos
studi
right
confidenti
written
inform
consent
obtain
particip
guardian
sproteincod
gene
optimis
conduct
oligonucleotid
synthesis
qingk
biotech
engin
servic
co
ltd
beij
accord
sprotein
sequenc
four
nonsarsrel
endem
hcov
genbank
leader
sequenc
origin
gene
remov
replac
human
tpa
leader
sequenc
aa
ntermin
fragment
artifici
synthesis
fragment
clone
eukaryot
express
plasmid
pvrc
gift
dr
gari
nabel
nih
usa
name
respect
figur
plasmid
dr
gari
nabel
nih
usa
sproteincod
gene
sarscov
construct
use
dna
vaccin
use
control
femal
balbc
mice
week
age
anim
care
centr
chines
academi
medic
scienc
beij
china
randomli
assign
four
group
accord
institut
anim
care
use
committe
iacuc
approv
protocol
mice
immunis
week
bled
week
mice
anaesthetis
prime
sexpress
plasmid
use
intraderm
inject
lower
dorsal
side
gene
deliveri
use
vivo
electropor
perform
describ
previous
serum
sampl
collect
week
last
vaccin
pool
anti
serum
individu
hcov
store
cell
transfect
individu
sexpress
plasmid
use
reagent
invitrogen
compani
h
posttransfect
cell
lyse
icecold
ripa
buffer
mm
trishcl
ph
mm
nacl
triton
sd
sodium
deoxychol
supplement
proteas
inhibitor
mixtur
sigma
st
loui
mo
lysat
kept
ice
min
centrifug
resolv
sdspage
polyacrylamid
gel
protein
transfer
nitrocellulos
membran
block
skim
milk
pb
h
incub
h
anti
mous
polyclon
antibodi
dilut
block
buffer
membran
wash
pb
contain
tween
incub
h
horseradish
peroxidaseconjug
antimous
secondari
antibodi
pierc
rockford
il
dilut
membran
wash
protein
visualis
supersign
chemiluminesc
substrat
pierc
ifa
use
detect
hcov
glycoprotein
express
cell
briefli
cell
seed
glass
slide
transfect
plasmid
respect
incub
co
cell
fix
paraformaldehyd
block
normal
goat
blood
serum
pb
infect
cell
incub
anti
mous
serum
h
incub
fitclabel
goat
antimous
igg
h
l
zhongahan
co
beij
china
min
posit
foci
identifi
fluoresc
microscopi
nikon
tokyo
japan
evan
blue
duplic
stain
serum
anti
igg
igm
detect
use
ifa
individu
hcov
glycoprotein
express
plasmid
use
transfect
ft
cell
flask
fortyeight
hour
later
transfect
cell
wash
twice
pb
drip
onto
slide
cell
fix
use
paraformaldehyd
min
permeabilis
use
wash
three
time
pb
antisspecif
antibodi
sera
dilut
quantifi
use
fitclabel
sheep
antihuman
igg
h
l
zhongahan
co
beij
china
fitclabel
antihuman
igm
slide
view
invert
fluoresc
microscop
olympu
tokyo
japan
serum
sampl
react
hcov
protein
dilut
consid
posit
anti
antibodi
duplic
tripl
test
consist
furthermor
confirm
nontransfect
cell
transfect
control
plasmid
express
protein
sarscov
react
human
serum
sampl
test
statist
analysi
perform
use
statist
packag
social
scienc
spss
statist
packag
test
fisher
exact
test
differ
mean
valu
group
consid
signific
p
assess
use
tukey
test
demograph
characterist
studi
subject
summaris
tabl
patient
subject
studi
infant
children
year
age
male
averag
age
adult
children
year
major
patient
child
popul
year
age
n
major
adult
year
age
n
structur
sfragment
individu
hcov
express
construct
use
studi
summaris
figur
express
hcov
protein
confirm
western
blot
figur
segment
detect
anti
mous
serum
deriv
dna
vaccin
individu
hcov
sexpress
plasmid
four
nonsarsrel
protein
show
band
size
consist
predict
molecular
mass
kda
presum
reflect
glycosyl
form
protein
addit
express
recombin
hcov
protein
confirm
immunofluoresc
stain
use
specif
anti
mous
serum
note
figur
protein
express
mainli
cytoplasm
membran
crossstain
observ
hcov
antiserum
use
primari
antibodi
specif
concern
virusantibodi
pair
subgroup
alphacoronavirus
batacoronavirus
furthermor
fals
positiveneg
result
observ
studi
data
shown
repres
antisposit
ifa
result
shown
figur
use
ifa
base
cell
express
individu
protein
hcov
investig
seropreval
virus
serum
variou
age
group
healthi
popul
beij
sampl
test
three
use
ifa
result
show
well
reproduc
serum
sampl
test
anti
igg
ifa
neg
anti
igg
hcov
tabl
serum
sampl
posit
signific
differ
gender
distribut
variat
trend
anti
igg
four
hcov
among
age
group
shown
figur
seroposit
rate
similar
level
among
group
p
proport
hcov
iggposit
sampl
increas
age
infanc
reach
level
age
year
interest
signific
drop
seroposit
rate
observ
group
group
child
popul
n
total
posit
rate
anti
igg
antibodi
figur
signific
differ
observ
regard
igg
two
novel
hcov
among
children
p
p
adult
popul
year
age
seropreval
anti
igg
differ
significantli
among
age
group
p
p
p
signific
increas
seropreval
rate
increas
age
observ
p
adult
popul
n
igg
posit
rate
proport
subject
detect
igg
antibodi
significantli
greater
p
furthermor
number
subject
igg
three
abovement
hcov
also
significantli
greater
p
howev
signific
differ
anti
igg
seroposit
rate
individu
hcov
respect
gender
either
child
adult
popul
data
shown
preval
variat
trend
anti
igm
antibodi
individu
hcov
among
child
popul
shown
figur
total
posit
rate
anti
igm
anti
igm
posit
rate
significantli
lower
three
hcov
p
signific
differ
anti
igm
seroposit
rate
individu
hcov
respect
gender
data
shown
signific
differ
anti
igm
posit
rate
individu
hcov
among
age
group
anti
igm
posit
rate
significantli
higher
three
hcov
among
group
figur
posit
rate
increas
age
began
drop
peak
schoolag
group
year
similar
describ
anti
igg
detect
anti
igm
antibodi
four
individu
hcov
detect
serum
healthi
adult
popul
year
age
first
comprehens
studi
evalu
anti
igg
igm
four
nonsar
hcov
among
gener
popul
china
first
time
show
anti
igm
present
children
indic
virus
first
infect
take
place
childhood
age
year
sar
epidem
origin
southern
china
spark
interest
area
coronaviru
research
four
endem
nonsarsrel
hcov
major
contributor
respiratori
tract
infect
clinic
manifest
howev
specif
feasibl
serolog
survey
hcov
especi
date
report
among
gener
popul
rare
china
spike
major
structur
protein
hcov
contain
multipl
conform
epitop
major
induc
antibodi
neutralis
lowest
sequenc
conserv
among
coronaviru
protein
render
specif
target
serodiagnosi
chose
hcov
gene
recombin
express
basi
current
knowledg
immunodomin
sarscov
antigen
belong
viru
famili
hcov
previou
studi
sarscov
serolog
success
use
protein
enzym
immunoassay
immunoblot
ifa
addit
comparison
protein
sequenc
four
hcov
reveal
protein
share
similar
hypothesis
differ
amino
acid
sequenc
suffici
high
ensur
use
protein
specif
antigen
antibodi
detect
nativ
surfac
protein
express
cell
recognis
postinfect
popul
serum
ifa
report
indic
cellbas
protein
express
system
differenti
falseposit
elisa
result
use
crossreact
nucleoprotein
antigen
furthermor
woo
et
al
report
rsbase
igm
elisa
sensit
rnbase
igm
elisa
sarscov
pneumonia
result
show
sbase
ifa
enabl
specif
detect
igg
igm
four
individu
hcov
use
ifa
investig
natur
seropreval
four
nonsarsrel
hcov
blood
sampl
gener
popul
compris
varieti
age
group
anti
igg
antibodi
four
nonsarsrel
hcov
detect
high
rate
among
healthi
adult
anti
igg
igm
antibodi
found
child
group
preval
increas
age
year
point
almost
plateau
data
suggest
exposur
hcov
common
childhood
first
infect
four
nonsar
hcov
take
place
children
moreov
found
evid
anti
igg
doubl
multipl
hcov
variou
combin
indic
larg
proport
gener
popul
beij
may
experi
infect
one
hcov
seropreval
hcov
antibodi
vari
wide
among
studi
use
differ
antigen
methodolog
previou
studi
nonsar
hcov
demonstr
seropreval
vari
greatli
depend
age
popul
ifa
studi
show
preval
four
anti
igg
antibodi
among
gener
chines
popul
slightli
higher
anoth
studi
germani
use
escherichia
coli
recombin
nbase
line
immunoassay
report
seroposit
healthi
blood
donor
hand
seroposit
rate
three
individu
hcov
exclud
studi
lower
anoth
studi
us
metropolitan
adult
popul
use
baculovirusexpress
recombin
nbase
elisa
show
seroposit
rate
also
suppos
significantli
differ
seroposit
rate
variou
hcov
might
result
individu
differ
demograph
factor
eg
ethnic
smoke
statu
socioeconom
statu
differ
suscept
individu
hcov
recent
studi
older
adult
veteran
underli
chronic
obstruct
pulmonari
diseas
seven
us
site
show
serum
igg
detect
least
subject
antibodi
identifi
subject
thu
eia
assay
use
whole
viru
n
protein
antigen
use
appar
crossreact
hcov
antibodi
demonstr
previous
may
detect
grouprath
typespecif
antibodi
result
regard
anti
igg
four
individu
hcov
children
correl
previou
seropreval
studi
although
data
limit
shao
et
al
found
antibodi
direct
children
year
age
older
frequent
detect
use
part
ctermin
region
n
protein
antibodi
captur
antigen
elisa
studi
children
netherland
age
year
indic
serum
sampl
posit
antibodi
respect
observ
preval
four
nonsarsrel
hcovdirect
igg
antibodi
among
children
year
age
almost
ident
inform
preval
anti
igm
nonsarsrel
hcov
todat
lack
first
investig
preval
anti
igm
four
individu
hcov
among
gener
popul
beij
use
ifa
anti
igm
individu
hcov
detect
portion
asymptomat
child
popul
anti
igm
seroposit
appear
increas
age
year
declin
sharpli
year
age
howev
anti
igm
individu
hcov
detect
healthi
adult
popul
result
suggest
primari
seroconvers
virus
occur
mainli
childhood
youth
addit
hcov
infect
might
result
seroconvers
children
asymptomat
subclin
manifest
result
also
agreement
hcov
molecular
epidemiolog
survey
indic
primari
exposur
occur
mainli
childhood
youth
conclud
sbase
ifa
might
use
specif
serolog
platform
epidemiolog
investig
hcov
infect
high
proport
children
adult
beij
show
anti
igg
seroposit
four
hcov
anti
igm
antibodi
detect
sera
asymptomat
children
four
nonsarsrel
hcov
appear
circul
gener
popul
sustain
hcov
infect
becom
like
increas
age
studi
may
serv
basi
prevent
control
nonsarsrel
hcov
infect
howev
research
need
determin
falseposit
neg
rate
associ
anti
ifa
determin
antibodi
titr
acut
convalesc
phase
primari
hcov
infect
comparison
serolog
method
antigen
prepar
well
sampl
exchang
facilit
valid
assay
individu
hcov
antibodi
determin
